Rita dos Santos Silva
I joined United Academics team in 2015, during my Master’s degree in Biomedical Sciences, at the VU Amsterdam. By that time, I was starting to realize that, more than planning scientific experiments, I was interested in understanding how science evolved and where it is going. After joining United Academics, it became clearer that open access must be the path for science advancement. In 2016, I became United Academics's editor-in-chief.
Pfizer’s Vaccine Offers Protection against Covid19, According to Early Data
Pfizer's mRNA-based vaccine candidate shows initial evidence of protection against Covid-19, the American pharmaceutical company announced today. Preliminary data from the phase 3 vaccine...
Infection with Sars-CoV-2 Renders a Robust Antibody Response for at least Three Months
Antibodies are one of the most valuable tools of the immune system to fight foreign invaders. As expected from work with other coronaviruses, several...
Social Distancing is a Natural Behaviour in Sick Bats
"If you are feeling sick, stay at home and avoid contact with people". You have probably lost count of the number of times you...
Covid-19 Candidate Vaccines Pass Safety and Efficacy Tests
Two candidate vaccines (ChAdOx1 and Ad-5-nCoV) for Covid-19 have been shown to be safe and efficacious in humans, according to two studies published this...
Asymptomatic Patients Appear to Have Lung Damage and Low Antibody Levels after SARS-CoV-2 Infection
The levels of antibody protection against SARS-CoV-2 infection may not last longer than a few months, reveals an article published last week on Nature...
Nearly Every Recovered Covid-19 Patient Has Antibodies Against the Virus
Most of the patients who recover from Covid-19 have antibodies against SARS-CoV2, the coronavirus that causes the disease, shows a study published in the...
Spain Orders Mandatory Quarantine for Incoming Travellers
From May 15, all travellers entering Spain will have to go through a mandatory 14-day quarantine, Spanish government officials have announced.
The measure applies...
Researchers Clone SARS-CoV2 in One Week
Cloning the novel SARS-coronavirus (SARS-CoV2) in the laboratory is now more rapid and efficient. A team of researchers from Bern, Switzerland, created a synthetic...
First Covid-19 Vaccine Trials Begin in the UK
Phase I of the new Covid-19 vaccine trials set up to begin today in the UK.
Spain to Ease Lockdown Rules for Children
Salvador Illa Roca, Spain’s health minister, announced yesterday that, from April 27, children under 14 may leave their houses for short walks, after nearly...